Home > Press > AlphaRx Announces Major Product Launch In China
AlphaRx (OTC BB:ALRX - News) AlphaRx, a leader in the development of Nanotechnology for Drug Delivery Platforms, announced a major product launch in China. Through AlphaRx International Holdings (AIH), its Hong Kong affiliate, AlphaRx will launch Indaflex(TM) in 2008. Already a successful topical arthritis relief product in Mexico, AIH is building a plant in China to meet the expected demand. AIH will also produce Dicloflex(TM), an eye-drop formula used to treat ocular inflammation and pain, as well as Vansolin(TM) and Zysolin(TM), used for serious infections such as lung inflammation and nosocomial pneumonia, for the rapidly growing Chinese market. Michael Lee, chairman of AlphaRx, said, "this is the beginning of a major push into the world's biggest market. And with a permanent presence in Hong Kong through AIH, we are here to succeed over the short- and long-term."
AlphaRx Announces Major Product Launch In China
MARKHAM, ON, Canada | Posted on December 6th, 2007
AlphaRx is a specialty pharmaceutical company utilizing proprietary site-specific nanoparticulate drug delivery systems to develop novel formulations of drugs that are insoluble or poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method. The Company also discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases and neurodegenerative diseases.
Forward Looking Statements:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the companies.
For more information, please click here
Nucap Investor Relations
629 Fifth Avenue,Suite 300
Pelham, NY 10803
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015
Iranian Researchers Planning to Produce Edible Insulin January 28th, 2015
Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015
Nanoliposomes Help Efforts to Cure Bacterial Infections January 27th, 2015
Advantest to Exhibit at SEMICON Korea in Seoul, South Korea February 4-6 Showcasing Broad Portfolio of Semiconductor Products, Technologies and Solutions January 29th, 2015
Park Systems Announces Innovations in Bio Cell Analysis with the Launch of Park NX-Bio, the only 3-in-1 Imaging Nanoscale Tool Available for Life Science Researchers January 29th, 2015
2015 Nanonics Image Contest January 29th, 2015
Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015
The Original Frameless Shower Doors Installs DFI's FuseCube™ to Offer Hydrophobic Protective Coating as a Standard Feature: First DFI FuseCube™ Installed on the East Coast to Enable Key Differentiator for the Original Frameless Shower Doors January 29th, 2015
Entanglement on a chip: Breakthrough promises secure communications and faster computers January 27th, 2015
Smart keyboard cleans and powers itself -- and can tell who you are January 21st, 2015
DNA 'glue' could someday be used to build tissues, organs January 14th, 2015